Live Breaking News & Updates on Cyrille touzeau

Stay informed with the latest breaking news from Cyrille touzeau on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Cyrille touzeau and stay connected to the pulse of your community

Three-Drug Regimen Is Safe for Newly Diagnosed Myeloma

A low rate of high-grade blood-related side effects following treatment with induction Dara-KRd and consolidation double transplant was discovered in a trial for patients with high-risk, newly diagnosed multiple myeloma.

Germany , German , Cyrille-touzeau , International-myeloma-society-annual-meeting , University-hospital-of-nantes , Department-of-hematology , Myeloma-society-annual , University-hospital , Myeloma ,

Daratumumab Plus KRd With Tandem Transplant Sustains Efficacy in High-Risk, Newly Diagnosed Myeloma

Induction daratumumab, carfilzomib, lenalidomide, and dexamethasone followed by consolidation double transplant sustained efficacy and safety in patients with high-risk, newly diagnosed multiple myeloma.

Germany , German , Cyrille-touzeau , University-hospital-of-nantes , International-myeloma-society-annual-meeting , Department-of-hematology , Myeloma-society-annual , University-hospital , Daratumumab , Carfilzomib , Lenalidomide , Dexamethasone

Investegate |Step Pharma Announcements | Step Pharma: Step Pharma to Present Promising Data on the Therapeutic Potential of Selective Small Molecule Inhibition of CTPS1 at the 64th American Society of Hematology Annual Meeting

Investegate announcements from Step Pharma, Step Pharma to Present Promising Data on the Therapeutic Potential of Selective Small Molecule Inhibition of CTPS1 at the 64th American Society of Hematology Annual Meeting

Saint-genis-pouilly , Rhôalpes , France , Louisiana , United-states , New-orleans , United-kingdom , American , Namrata-taak , Niklas-zojer , Benoit-tessoulin , Cyrille-touzeau

Elotuzumab Combination Disappoints in Newly Diagnosed Myeloma

Study failed to replicate positive results seen in relapsed/refractory setting

Athens , Attikír , Greece , France , Massachusetts , United-states , Meletios-dimopoulos , Mike-bassett , Cyrille-touzeau , Touzeauc-elotuzumab , University-hospital , University-of-athens-school-medicine